Profiel
James Wooldridge is currently the Chief Medical Officer at Checkmate Pharmaceuticals, Inc. He previously worked as the Chief Medical Officer at Spyre Therapeutics, Inc. from 2017 to 2019 and as the Chief Scientific Officer at Eli Lilly & Co. He received his doctorate degree from Tulane University in 1992 and his undergraduate degree from William Jewell College in 1988.
Actieve functies van James Wooldridge
| Bedrijven | Functie | Begin |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2019 |
Eerdere bekende functies van James Wooldridge
| Bedrijven | Functie | Einde |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 10-10-2019 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Opleiding van James Wooldridge
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
William Jewell College
William Jewell College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
















